Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru

Objective: To determinate the frequency of Streptococcus pneumoniae nasopharyngeal carriers, serotypes and antimicrobial resistance in healthy children in Lima, Peru, post-PCV13 introduction and to compare the results with a similar study conducted between 2006 and 2008 before PCV7 introduction (pre-PCV7). Methods: A cross-sectional multicenter study was conducted between January 2018 and August 2019 in 1000 healthy children under two years of age. We use standard microbiological methods to determinate S. pneumoniae from nasopharyngeal swab, Kirby Bauer and minimum inhibitory concentration methods to determinate antimicrobial susceptibility and whole genomic sequencing to determinate pneumococcal serotypes. Results: The pneumococcal carriage rate was 20.8 % vs. 31.1 % in pre-PCV7 (p < 0.001). The most frequent serotypes were 15C, 19A and 6C (12.4 %, 10.9 % and 10.9 % respectively). The carriage of PCV13 serotypes after PCV13 introduction decreased from 59.1 % (before PCV7 introduction) to 18.7 % (p < 0.001). Penicillin resistance was 75.5 %, TMP/SMX 75.5 % and azithromycin 50.0 %, using disk diffusion. Penicillin resistance rates using MIC breakpoint for meningitis (MIC & GE; 0.12) increased from 60.4 % to 74.5 % (p = 0.001). Conclusion: The introduction of PCV13 in the immunization program in Peru has decreased the pneumo-coccal nasopharyngeal carriage and the frequency of PCV13 serotypes; however, there has been an increase in non-PCV13 serotypes and antimicrobial resistance. & COPY; 2023 Published by Elsevier Ltd.

Automated summary

This study aimed to determine the frequency of Streptococcus pneumoniae nasopharyngeal carriers, serotypes, and antimicrobial resistance in healthy children in Lima, Peru, after the introduction of PCV13, and compare the results with a previous study conducted before the introduction of PCV7. The study found that the introduction of PCV13 resulted in a decrease in pneumococcal nasopharyngeal carriage and the frequency of PCV13 serotypes, but an increase in non-PCV13 serotypes and antimicrobial resistance.